ID part 2 Resistant enzymes and treatments Flashcards
ESBLs
identified with CTX-M present
Most common in E. Coli, Klebsiella, Proteus mirabilis
Treatment of choice is carbapenems
Meropenem, Impenem, Doripenem, Ertapenem
Carbapenemase
Identified with KPC present
Most common in K. Pneumonia, K. Oxytoca, E.Coli, E. Cloacae, E. Aerogenes, P. Mirabills
Causes resistance to whole B- lactam class (Penecillins, Cephalosporins, carbapenems, Monobactams)
Treatment of choice is usually a b-lactam with a b-lactamase inhibitor
Avycaz - ceftazidime/avibactam
Vabomere - meropenem/vaborbactam
Metallo-B-Lactamases
Identified with NDM
present in P. aeruginosa, Acinetobacter spp., and enterobacterales
Resistance to all B-lactams except monobactams (aztreonam)
Treatment Cefiderocol
OXA-Type
Identified with OXA-48
Common in Acinetobacter baumannii and Pseudomonas aeruginosa
Treatment: Cefiderocol or Sulbactam/durlobactam
AmpC inducible mechanism
AmpC helps recycle cell wall degredation products but can be a b-Lactamase at low levels
AmpG brings in degredation products to the iner membrane and AmpD generates UDP-N- acetyl which will bind to AmpR and turn off AmpC which is desired
Presence of B-Lactam is AmpG is bringing in degredation products faster and AmpD cannot make UDP fast enought and these degredation products then compete to bind to AmpR which turns on the AmpC gene and cause hyperexpresion of AmpC b-lactamases to inactivate our B-Lactam drugs (if we remove inducer we can go back to normal state)
Problem arises when there are Mutations specifically in AmpD so the degradation products continuously stimulate AmpC b-lactamase production without b-lactam present
AmpC inducers
Found in Hafnia alvei, Enterobacter cloacae, Citrobacter freudii, Klebsiella aerogenes, Yersinia enterocolitica (HECK YES) - EXAM Q
Most commonly seen in Enterobacter cloacae, Citrobacter freudii, Klebsiella aerogenes,
Strong inducers of AmpC
Penicillin G, ampicillin
Weak Inducers of AmpC
Ceftriaxone is known to induce AmpC the most out of other 3rd generation Cephalosporins and patient will become resistant if AmpC is activated
AmpC treatment
Cefepime - still a weak inducer of AmpC but it is still able to work even with AmpC induced
Second line treatment is carbapenems (meropenem, Imipenem)
Resistance to vancomycin
Target site (D-Ala-D-Ala) alteration that leads to resistance
Rapid diagnostic test will show VanA or VanB
Treatment: Daptomycin or linezolid
Penicillin binding proteins (PBPs) resistance
Leads to beta lactam resistance
ususally seen as Methicillin resistant staphylococcus aureus
Epressed by mecA gene
Treatment: Ceftaroline, Ceftobiprole, vancomycin, daptomycin, linezolid
Efflux pumps resistance
Important resistance mechanism for P aeruginosa